125 related articles for article (PubMed ID: 28972423)
1. Autoimmune manifestations associated with lymphoma: characteristics and outcome in a multicenter retrospective cohort study.
Jachiet V; Mekinian A; Carrat F; Grignano E; Retbi A; Boffa JJ; Ronco P; Rondeau E; Sellam J; Berenbaum F; Chazouillères O; Capron J; Alamowitch S; Chasset F; Frances C; Coppo P; Fain O;
Leuk Lymphoma; 2018 Jun; 59(6):1399-1405. PubMed ID: 28972423
[TBL] [Abstract][Full Text] [Related]
2. The dual association between lymphoma and autoimmunity.
Ehrenfeld M; Abu-Shakra M; Buskila D; Shoenfeld Y
Blood Cells Mol Dis; 2001; 27(4):750-6. PubMed ID: 11778659
[TBL] [Abstract][Full Text] [Related]
3. Clinical features and outcome of lymphoma patients with pre-existing autoimmune diseases.
Shih YH; Yang Y; Chang KH; Chen YH; Teng CJ
Int J Rheum Dis; 2018 Jan; 21(1):93-101. PubMed ID: 29205866
[TBL] [Abstract][Full Text] [Related]
4. History of autoimmune conditions and lymphoma prognosis.
Kleinstern G; Maurer MJ; Liebow M; Habermann TM; Koff JL; Allmer C; Witzig TE; Nowakowski GS; Micallef IN; Johnston PB; Inwards DJ; Thompson CA; Feldman AL; Link BK; Flowers C; Slager SL; Cerhan JR
Blood Cancer J; 2018 Aug; 8(8):73. PubMed ID: 30069001
[TBL] [Abstract][Full Text] [Related]
5. Presence of autoimmune disease affects not only risk but also survival in patients with B-cell non-Hodgkin lymphoma.
Kleinstern G; Averbuch M; Abu Seir R; Perlman R; Ben Yehuda D; Paltiel O
Hematol Oncol; 2018 Apr; 36(2):457-462. PubMed ID: 29469175
[TBL] [Abstract][Full Text] [Related]
6. Clinical manifestations of autoimmune disease-related non-Hodgkin lymphoma: a Korean single-center, retrospective clinical study.
Jeon YW; Yoon JH; Lee SE; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Lee JW; Min WS; Cho SG
Korean J Intern Med; 2016 Sep; 31(5):944-52. PubMed ID: 27384438
[TBL] [Abstract][Full Text] [Related]
7. Chronic viral hepatitis and risk of lymphoid malignancies: a retrospective twelve-year population-based cohort study in Côte d'Or, France.
Proby C; Minello A; Quantin C; Jooste V; Binquet C; Hägi M; Mounier M; Benzenine E; Hillon P; Maynadié M
Dig Liver Dis; 2012 Feb; 44(2):160-5. PubMed ID: 21975433
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and clinical impact of autoimmune diseases and chronic infections in malignant lymphomas at diagnosis.
Vanura K; Späth F; Gleiss A; Le T; Porpaczy E; Skrabs C; Hauswirth A; Fleiss K; Wessely F; Gaiger A; Müllauer L; Jäger U
Ann Hematol; 2011 Aug; 90(8):947-54. PubMed ID: 21327940
[TBL] [Abstract][Full Text] [Related]
9. [Hodgkin disease and autoimmunity in children: 11 case reports].
Jarrassé C; Pagnier A; Edan C; Landman-Parker J; Mazingue F; Mansuy L; Bertrand Y; Paillard C; Pellier I; Margueritte G; Plantaz D
Arch Pediatr; 2011 Apr; 18(4):376-82. PubMed ID: 21397466
[TBL] [Abstract][Full Text] [Related]
10. A single unit lymphoma experience: outcome in a Cape Town academic centre.
Wood L; Robinson R; Gavine L; Juritz J; Jacobs P
Transfus Apher Sci; 2007 Aug; 37(1):93-102. PubMed ID: 17931976
[TBL] [Abstract][Full Text] [Related]
11. Conjunctival Lymphoma--An International Multicenter Retrospective Study.
Kirkegaard MM; Rasmussen PK; Coupland SE; Esmaeli B; Finger PT; Graue GF; Grossniklaus HE; Honavar SG; Khong JJ; McKelvie PA; Mulay K; Prause JU; Ralfkiaer E; Sjö LD; Toft PB; Vemuganti GK; Thuro BA; Curtin J; Heegaard S
JAMA Ophthalmol; 2016 Apr; 134(4):406-14. PubMed ID: 26891973
[TBL] [Abstract][Full Text] [Related]
12. Improvement of survival in patients with primary cutaneous diffuse large B-cell lymphoma, leg type, in France.
Grange F; Joly P; Barbe C; Bagot M; Dalle S; Ingen-Housz-Oro S; Maubec E; D'Incan M; Ram-Wolff C; Dalac S; Templier I; Esteve E; Quereux G; Machet L; Leduc M; Dereure O; Laroche L; Saiag P; Vergier B; Beylot-Barry M
JAMA Dermatol; 2014 May; 150(5):535-41. PubMed ID: 24647650
[TBL] [Abstract][Full Text] [Related]
13. Gray zone lymphoma with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma: characteristics, outcomes, and prognostication among a large multicenter cohort.
Evens AM; Kanakry JA; Sehn LH; Kritharis A; Feldman T; Kroll A; Gascoyne RD; Abramson JS; Petrich AM; Hernandez-Ilizaliturri FJ; Al-Mansour Z; Adeimy C; Hemminger J; Bartlett NL; Mato A; Caimi PF; Advani RH; Klein AK; Nabhan C; Smith SM; Fabregas JC; Lossos IS; Press OW; Fenske TS; Friedberg JW; Vose JM; Blum KA
Am J Hematol; 2015 Sep; 90(9):778-83. PubMed ID: 26044261
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of elevated antinuclear antibody test in patients with Hodgkin's and Non-Hodgkin's lymphoma: a single center experience.
Altintas A; Cil T; Pasa S; Danis R; Kilinc I; Ayyildiz O; Muftuoglu E
Minerva Med; 2008 Feb; 99(1):7-14. PubMed ID: 18299692
[TBL] [Abstract][Full Text] [Related]
15. Malignant lymphomas in autoimmunity and inflammation: a review of risks, risk factors, and lymphoma characteristics.
Smedby KE; Baecklund E; Askling J
Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2069-77. PubMed ID: 17119030
[TBL] [Abstract][Full Text] [Related]
16. Malignant lymphoma-associated autoimmune diseases--a descriptive epidemiological study.
Váróczy L; Gergely L; Zeher M; Szegedi G; Illés A
Rheumatol Int; 2002 Nov; 22(6):233-7. PubMed ID: 12426661
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune and inflammatory disorders and risk of malignant lymphomas--an update.
Smedby KE; Askling J; Mariette X; Baecklund E
J Intern Med; 2008 Dec; 264(6):514-27. PubMed ID: 19017176
[TBL] [Abstract][Full Text] [Related]
18. Hematologic malignancies in patients with cryoglobulinemia: association with autoimmune and chronic viral diseases.
Trejo O; Ramos-Casals M; López-Guillermo A; García-Carrasco M; Yagüe J; Cervera R; Font J; Ingelmo M
Semin Arthritis Rheum; 2003 Aug; 33(1):19-28. PubMed ID: 12920693
[TBL] [Abstract][Full Text] [Related]
19. Paraneoplastic autoimmune cytopenias in Hodgkin lymphoma.
Lechner K; Chen YA
Leuk Lymphoma; 2010 Mar; 51(3):469-74. PubMed ID: 20141438
[TBL] [Abstract][Full Text] [Related]
20. Patients with systemic lupus erythematosus (SLE) having developed malignant lymphomas. Complete remission of lymphoma following high-dose chemotherapy, but not of SLE.
Rossi E; Catania G; Truini M; Ravetti GL; Grassia L; Marmont AM
Clin Exp Rheumatol; 2011; 29(3):555-9. PubMed ID: 21722503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
